Louisville, Colorado – July 14 2025 – Synergy Spine Solutions, an innovative orthopaedic medical device company focused on artificial cervical disc replacement, today announced the expansion of its sales agency agreement with Johnson & Johnson MedTech Switzerland.
The expansion of this agreement into Switzerland is effective April 1, 2025, and builds on the success of the existing sales agency agreements with Johnson & Johnson Medtech across the United Kingdom and the Republic of Ireland. The inclusion of Switzerland, a key European market for spine innovation, represents a strategic step forward in expanding access to the Synergy Disc® for spine surgeons and their patients.
The expansion of this sales relationship marks the continued momentum behind the Synergy Disc®, the only artificial cervical disc with a 6° lordotic core that combines cervical alignment and balance with natural motion for patients with degenerative disc disease (DDD) causing radiculopathy and / or myelopathy.
The unique design of the Synergy Disc® utilises time-tested materials that are aligned with the stringent standards of Johnson & Johnson MedTech and their role as a global leader in orthopaedic and spine technology.
The agreement reflects a shared commitment to bringing innovation to spine surgery through a strong commercial infrastructure, deep clinical knowledge, and surgeon-first focus.
– Ends –
